AnaghaBangalore KumarMD

PubMed

• 1 citations
  Bridging the gap in BASCULE syndrome: A retrospective case series of a recently described clinical entity.
  Jacob P Reinhart, Anagha Bangalore Kumar, Ana I Casanegra, Thom W Rooke, Julio C Sartori-Valinotti, Megha M Tollefson, Kelsey M Klaas, Dawn M Davis> ;Pediatric Dermatology. 2023 Nov 28
• 2 citations
  Association of BRAF V600E Status of Incident Melanoma and Risk for a Second Primary Malignancy: A Population-Based Study.
  Soogan C Lalla, Anagha Bangalore Kumar, Julia S Lehman, Christine M Lohse, Jerry D Brewer> ;Cutis. 2022 Sep 1
• Primary cutaneous melanoma features predict development of in-transit metastases/satellite lesions: Mayo Clinic experience, 2010 to 2014.
  Anagha Bangalore Kumar, Margot S Peters, James W Jakub, William Harmsen, Christian L Baum> ;Journal of the American Academy of Dermatology. 2023 Feb 1
• 6 citations
  Reactive granulomatous dermatitis as a clinically relevant and unifying term: a retrospective review of clinical features, associated systemic diseases, histopathology...
  A Bangalore Kumar, J S Lehman, E F Johnson, H M Cantwell, J C Sartori Valinotti, O Sokumbi, M D P Davis, D A Wetter> ;Journal of the European Academy of Dermatology and Venereology. 2022 Dec 1
• Chronic non-healing facial ulcer: Trigeminal trophic syndrome from underlying paraneoplastic antibodies.
  Nicholas A. Berry, Anagha Bangalore Kumar, David A. Wetter> ;International Journal of Dermatology. 2021 Sep 29
• 30 citations
  Chemo-immunotherapy combination after PD-1 inhibitor failure improves clinical outcomes in metastatic melanoma patients
  Jesus Vera Aguilera, Jonas Paludo, Robert R. McWilliams, Henan Zhang, Ying Li, Anagha Bangalore Kumar, Jarrett J. Failing, Lisa A. Kottschade, Matthew S. Block, Svetom...> ;Melanoma Research. 2020 Aug 1
• 13 citations
  Trichotillomania (hair pulling disorder): Clinical characteristics, psychosocial aspects, treatment approaches, and ethical considerations
  Katlein França, Anagha Bangalore Kumar, David E. Castillo, Mohammad Jafferany, Marcelo Hyczy da Costa Neto, Katerina Damevska, Uwe Wollina, Torello Lotti> ;Dermatologic Therapy. 2019 Jul 1
• 21 citations
  Treatment of morphea with hydroxychloroquine: A retrospective review of 84 patients at Mayo Clinic, 1996-2013.
  Anagha Bangalore Kumar, Lisa A. Drage, Rokea A. el-Azhary, David A. Wetter, Elizabeth K. Blixt> ;Journal of the American Academy of Dermatology. 2019 Jun 1
• The role of serum lactate dehydrogenase level as a prognostic indicator in resected, high risk melanoma
  Anagha Bangalore Kumar, Jesus Vera Aguilera, Ana I. Velazquez, Yiyi Yan, James W. Jakub, Jerry D. Brewer, Tina J. Hieken, Matthew S. Block, Robert R. McWilliams, Clark...> ;Dermatologic Therapy. 2019 Jan 30
• 23 citations
  Premature Graying of Hair: Review with Updates.
  Anagha Bangalore Kumar, Huma Shamim, Umashankar Nagaraju> ;International Journal of Trichology. 2018 Sep 1
• 147 citations
  Combining Immune Checkpoint Inhibitors With Conventional Cancer Therapy.
  Yiyi Yan, Anagha Bangalore Kumar, Heidi D. Finnes, Svetomir N. Markovic, Sean S. Park, Roxana S. Dronca, Haidong Dong> ;Frontiers in Immunology. 2018 Jul 27
• 3 citations
  Pharmacologic Modulation of Human Immunity in the Era of Immuno-oncology: Something Old, Something New
  Anagha Bangalore Kumar, Rachel L. Maus, Svetomir N. Markovic> ;Mayo Clinic Proceedings. 2018 Jul 1
• Rethinking the prescription of biotin for dermatologic conditions.
  Anagha Bangalore Kumar, Torello Lotti, Katlein França> ;Dermatologic Therapy. 2018 Jul 1
• 15 citations
  The history of Botulinum toxin: from poison to beauty.
  Katlein França, Anagha Kumar, Massimo Fioranelli, Torello Lotti, Michael Tirant, Maria Grazia Roccia> ;Wiener Medizinische Wochenschrift. 2017 Mar 15
• Join now to see all

Journal Articles

• The role of serum lactate dehydrogenase (LDH) level as a prognostic indicator in resected, high risk melanoma  
  Anagha Bangalore Kumar , Jesus Vera Aguilera , Ana Velazquez , Yiyi Yan , James Jakub , Jerry Brewer , Tina Hieken , Matthew Block , Robert McWilliams , Clark Otl..., Dermatologic Therapy, 1/30/2019
• Treatment of morphea with hydroxychloroquine: A retrospective review of 84 patients at Mayo Clinic, 1996-2013  
  Anagha Bangalore Kumar, MBBS Elizabeth K. Blixt, MD Lisa A. Drage, MD Rokea A. el-Azhary, MD, PhD David A. Wetter, MD, Journal of the American Academy of Dermatology, 1/28/2019